Introduction
While advances in immunosuppression and transplant techniques have significantly increased the short-term survival of solid organ transplant recipients, long-term graft and patient outcomes still need to be improved in solid organ transplantation. Researchers from various fields and with a variety of resources and areas of expertise highlighted the novelty of their most recent studies in the field of organ transplantation in this Special Issue, which also addressed issues regarding donors, allografts, and patient survival. While there have been significant advances in regional and national kidney paired-donation programs in matching incompatible pairs, data suggest that there may be a role for desensitization in select cases to facilitate organ transplantation. In this Special Issue, Weinhard et al. summarized the roles of tocilizumab and desensitization in kidney transplant candidates. In addition to progress in desensitization and preoperative monitoring of donor-specific antibodies, this Special Issue also provided insights into the monitoring and management of chronic active antibody-mediated rejection.
Furthermore, investigators also shed light on post-transplant complication research, including osteoporotic fractures, diarrhea, psychological changes, and recurrent primary disease. Immunosuppression management is essential for patient and graft survival in transplant recipients, and studies have demonstrated the impacts of tacrolimus metabolism rates on outcomes after transplantation. In this Special Issue, Kolonko et al. found the novel findings of influences of body composition parameters assessed by bioimpedance analysis on the tacrolimus metabolism, which may potentially be useful in optimizing initial tacrolimus dosing. Additionally, while fast tacrolimus metabolism is associated with lower renal function after kidney transplantation , in this Special Issue, Thölking et al. found no significant impact of fast tacrolimus metabolism on dyslipidemia parameters. Better understanding of subgroups of transplant recipients, such as older transplant recipients and Black transplant recipients, can help the transplant community to identify individualized strategies to improve outcomes among these vulnerable populations.
In this Special Issue, Zompolas et al. conducted a retrospective study to evaluate outcomes of 85 kidney transplant recipients aged ≥75 years in the Eurotransplant Senior Program from January 2010 to July 2018 at the Charité-Universitätsmedizin Berlin in Germany. The investigators demonstrated comparable outcomes among older patients compared to their younger counterparts, confirming excellent outcomes, including in patient and graft survival, in carefully selected older kidney transplant recipients aged ≥ 75 years. Lastly, in this Special Issue, we reported outcomes of kidney transplant recipients with sickle cell disease (SCD) from an analysis of the 2000–2019 United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network Database. In this study, we found that SCD was significantly associated with lower patient survival and death-censored graft survival compared to non-SCD recipients. The findings of our study suggest that urgent future studies are required to identify strategies to improve outcomes in SCD kidney recipients. Additionally, the assignment of risk adjustment for SCD patients should be considered.
Summary
In summary, the findings published in this Special Issue provide novelty and additional knowledge and may help the transplant community to ultimately improve the management and outcomes of patients with solid organ transplantation.
References:
1. Lentine, K.L.; Smith, J.M.; Hart, A.; Miller, J.; Skeans, M.A.; Larkin, L.; Robinson, A.; Gauntt, K.; Israni, A.K.; Hirose, R.; et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am. J. Transplant. 2022, 22, 21–136.
2. Thongprayoon, C.; Hansrivijit, P.; Leeaphorn, N.; Acharya, P.; Torres-Ortiz, A.; Kaewput, W.; Kovvuru, K.; Kanduri, S.R.; Bathini, T.; Cheungpasitporn, W. Recent Advances and Clinical Outcomes of Kidney Transplantation. J. Clin. Med. 2020, 9, 1193.
3. Larpparisuth, N.; Cheungpasitporn, W.; Lumpaopong, A. Global Perspective on Kidney Transplantation: Thailand. Kidney360 2021, 2, 1163–1165.
4. Divard, G.; Goutaudier, V. Global Perspective on Kidney Transplantation: France. Kidney360 2021, 2, 1637–1640.
5. Zhang, Z.; Liu, Z.; Shi, B. Global Perspective on Kidney Transplantation: China. Kidney360 2021, 2, 364.
6. All-Time Records Again Set in 2021 for Organ Transplants, Organ Donation from Deceased Donors. Available online: https://unos.org/news/2021-all-time-records-organ-transplants-deceased-donor-donation(accessed on 2 April 2022).
7. Thongprayoon, C.; Kaewput, W.; Kovvuru, K.; Hansrivijit, P.; Kanduri, S.R.; Bathini, T.; Chewcharat, A.; Leeaphorn, N.; Gonzalez-Suarez, M.L.; Cheungpasitporn, W. Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation. J. Clin. Med. 2020, 9, 1107.
8. El-Bandar, N.; Lerchbaumer, M.H.; Peters, R.; Maxeiner, A.; Kotsch, K.; Sattler, A.; Miller, K.; Schlomm, T.; Hamm, B.; Budde, K.; et al. Kidney Perfusion in Contrast-Enhanced Ultrasound (CEUS) Correlates with Renal Function in Living Kidney Donors. J. Clin. Med. 2022, 11, 791.
9. Jehn, U.; Kortenhorn, A.; Schütte-Nütgen, K.; Thölking, G.; Westphal, F.; Strauss, M.; Wennmann, D.O.; Pavenstädt, H.; Suwelack, B.; Görlich, D.; et al. The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial. J. Clin. Med. 2022, 11, 654.
10. Kolonko, A.; Pokora, P.; Słabiak-Błaz, N.; Czerwienska, B.; Karkoszka, H.; Kuczera, P.; Piecha, G.; Wiecek, A. The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation. J. Clin. Med. 2021, 10, 5793.
